COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs

In the Wuhan Province of China, in December 2019, the novel coronavirus 2019 (COVID-19) has caused a severe involvement of the lower respiratory tract leading to an acute respiratory syndrome. Subsequently, coronavirus 2 (SARS-CoV-2) provoked a pandemic which is considered a life-threatening disease...

Descripción completa

Detalles Bibliográficos
Autores principales: TUFAN, Abdurrahman, AVANOĞLU GÜLER, Aslıhan, MATUCCI-CERINIC, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195984/
https://www.ncbi.nlm.nih.gov/pubmed/32299202
http://dx.doi.org/10.3906/sag-2004-168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195984/
https://www.ncbi.nlm.nih.gov/pubmed/32299202
http://dx.doi.org/10.3906/sag-2004-168

Ejemplares similares